Loading company…
Xdynia develops Cav3.2-blocking drugs for the prevention and treatment of neuropathic pain.
Xdynia is a startup pharmaceutical company developing drugs that block Cav3.2 for the prevention and treatment of neuropathic pain. The company is based in Charlottesville, US, and was at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in